Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Jul 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.0M
Net Open-Market Flow
-$5.0M
Transactions
12
11 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 16, 2026Option exercise(M)10K$135.42$1.3M334K
Jul 16, 2026Sell(S)80$527.31$42K334K
Jul 16, 2026Sell(S)1K$528.42$740K332K
Jul 16, 2026Sell(S)3K$529.46$1.6M329K
Jul 16, 2026Sell(S)2K$530.14$1.0M327K
Jul 16, 2026Sell(S)520$532.14$277K327K
Jul 16, 2026Sell(S)440$533.28$235K327K
Jul 16, 2026Sell(S)1K$534.31$640K325K
Jul 16, 2026Sell(S)720$535.20$385K325K
Jul 16, 2026Sell(S)150$536.29$80K324K
Jul 16, 2026Sell(S)11$537.11$6K324K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 16, 2026Option exercise(M)10K$0332K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000100) within minutes of acceptance. Every field above traces to the original document. Verify it directly: